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Purpose: In OA cartilage, the metabolic activity of chondrocytes
is altered dramatically by site, but the mechanism(s) for the
changes is not known well. The purpose of this study is to deter-
mine possible regulatory molecules for chondrocyte anabolism
in OA.
Methods: In order to determine the candidate molecules which
may regulate chondrocyte anabolism in OA, cartilages were ob-
tained from 10 end-stage OA knees at macroscopically preserved
areas and degenerated areas. RNA was extracted from the 10
pairs of cartialge samples, and the proﬁles of gene expression at
respective areas were determined by microarray analysis (U133
Plus 2.0, Affymetrix). Linear regression analysis was performed
to evaluate the relatiohship between the expression of type II
collagen or aggrecan and that of the growth factors which were
known to have anabolic effects on chondrocytes (TGF-βs, BMPs,
IGFs, CTGF). The correlation was also investigated between
the cartilage matrices and receptors and endogenous inhibitors
for the growth factors. Further, the correlation was investigated
between the cartilage matrices and the cartilage related SOXs
(SOX5, SOX6, SOX9).
For some candidate molecules, the correlation of expression was
conﬁrmed by an analysis using real-time PCR and laser capture
microdissection (LCM). For this, OA cartilages were acquired
from another 10 OA knees at various sites in preserved and
degenerated areas. Cryosections were prepared and divided into
three cartilage zones (superﬁcial, middle, and deep zones) by
LCM (PixCell IIe, Arcturus). The expression of cartilage matrices
and candidate molecules was evaluated in respective zones by
real-time PCR.
Results: In the microarray analysis, a signiﬁcant correlation
was observed between the expression of type II collagen and
aggrecan, which was conﬁrmed by the real-time PCR analysis
coupled with LCM. The result of microarray analysis revealed
that the expression of type II collagen was positively correlated
with that of IGF-2 and TGF-β receptors (Table 1). Of these, the
signiﬁcance of correlation between type II collagen and IGF-2
was conﬁrmed by the real-time PCR analysis. Meanwhile, the
expression of aggrecan was positively correlated with that of IGF-
Table 1. Correlation of expression between cartilage matrices and growth fac-
tors, growth factor related molecules
Cartilage Growth factors and related molecules
matrices Positively correlated Negatively correlated
Type II collagen IGF-2* (r = 0.59, P < 0.01)
TGF-β RI (r = 0.45, P < 0.05)
TGF-β RII (r = 0.47, P < 0.05)
Aggrecan IGF-2* (r = 0.78, P< 0.01) IGFBP-1 (r = -0.60, P < 0.01)
IGF-2 R (r = 0.78, P < 0.01) IGFBP-3* (r = -0.65, P < 0.01)
IGFBP-4 (r = -0.64, P < 0.01)
IGFBP-5 (r = -0.68, P < 0.01)
IGFBP-6 (r = -0.64, P < 0.01)
IGFBP-7* (r = -0.62, P < 0.01)
TGF-β1* (r = 0.70, P < 0.01) LTBP-I (r = -0.47, P < 0.05)
TGF-β RII (r = 0.66, P < 0.01) LTBP-2 (r = -0.46, P < 0.05)
TGF-β RIII (r = 0.79, P < 0.01) LTBP-3 (r = -0.46, P < 0.05)
*signiﬁcance of correlarion was conﬁrmed by real-time PCR analysis. IGFBP,
IGF binding protein; LTBP, latent TGF-β binding protein.
2, IGF-2 receptor, TGF-β1, and TGF-β receptors, and negatively
correlated with that of IGF binding proteins and latent TGF-β
binding proteins (Table 1). The real-time PCR analysis conﬁrmed
signiﬁcant correlations between aggrecan and IGF-2, TGF-β1,
and IGF binding proteins-3 and -7.
The expression of type II collagen and aggrecan was both
signiﬁcantly correlated with that of SOX9, but not with SOX5 or
SOX6, which was also conﬁrmed by the real-time PCR analysis.
Conclusions: Although the anabolic activity of chondrocytes is
highly enhanced in the preserved areas in OA cartilage, it is
considerably reduced at the degenerated areas, which may be
responsible for the loss of cartilage matrix in OA. The result
of this study suggested that the change in IGF-2 and TGF-β1
activities may account for such regional difference in chondrocyte
anabolism. SOX9 could be another factor for the regional change,
though the relationship between SOX9 and the above two growth
factors is still left to be determined. Although further experiments
are necessary, this result could be a novel clue to dissect the
mechanisms for altered chondrocyte metabolism in OA.
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INORGANIC PYROPHOSPHATEGENERATION BY
TUMOR GROWTH FACTOR-BETA1 IS MAINLY
DEPENDENT ON ANK INDUCTION BY
RAS/RAF-1/EXTRACELLULARREGULATED KINASE
PATHWAYS IN CHONDROCYTES
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Purpose: Sporadic chondrocalcinosis is a common human dis-
order characterized by the deposition of calcium-containing crys-
tals, mostly calcium pyrophosphate dihydrate (CPPD), within
articular cartilage. ANK is a multipass transmembrane protein
transporter, thought to play a role in the export of intracellu-
lar inorganic pyrophosphate (iPPi), and so to be implicated in
chondrocalcinosis. Two others proteins play a major role in the
metabolism of inorganic pyrophosphate: PC-1, that generates
extracellular inorganic pyrophosphate (ePPi) from nucleotides
triphosphates, and TNAP (Tissue Non speciﬁc Alkaline Phos-
phatase), that cleaves one molecule of ePPi into two molecules
of extracellular inorganic phosphate (ePi). Transforming growth
factor-β1 (TGF-β1) was shown to enhance ePPi production by
articular chondrocytes, markedly in old patients than in young
patients, this was closely related to the occurrence of sporadic
chondrocalcinosis. Therefore, we investigated the contribution of
ANK to the production of extracellular ePPi by chondrocytes and
the signaling pathways involved in the regulation of Ank gene by
TGF-β1.
Methods: Chondrocytes were exposed to 10 ng/ml of TGF-β1,
and Ank expression was measured by quantitative PCR and
Western blot analyses. ePPi and ePi were quantiﬁed concomi-
tantly by a ﬂuorescence assay in cell supernatants. SiRNA tech-
nology was used to deﬁne the respective role of Ank and PC-1
in TGF-β1-induced ePPi generation. Finally, selective inhibitors
and dominant negative/constitutively active overexpression plas-
mids strategy were used to explore the contribution of Ras,
Raf-1, MAPKs (ERK 1/2 and p38 MAPK), Smad, PKA and PKC
pathways to Ank induction by TGF-β1.
Results: TGF-β1 strongly increased Ank expression, maximally
by 4.5 fold at the mRNA and by 4-fold at the protein level. PC-1
mRNA and protein levels were induced with the same intensity,
but in a more delayed fashion, whereas TNAP was repressed
by 2-fold under TGF-β1 stimulation. Moreover, ePPi production
was induced 5-fold after 24 h TGF-β1 exposure, whereas ePi
levels were not affected under the same conditions. Then, we
